Search

Jermie E Cozart

Examiner (ID: 17502, Phone: (571)272-4528 , Office: P/3726 )

Most Active Art Unit
3726
Art Unit(s)
3728, 3799, 3726
Total Applications
2110
Issued Applications
1676
Pending Applications
108
Abandoned Applications
326
Created with Highcharts 8.2.2Number of ApplicationsStatus of ApplicationsIssuedAbandoned2000200220042006200820102012201420162018202020222024050100150200

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18389820 [patent_doc_number] => 20230158038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF IN A SUBJECT HAVING INFLUENZA AND A COMPLICATION RISK FACTOR [patent_app_type] => utility [patent_app_number] => 18/152449 [patent_app_country] => US [patent_app_date] => 2023-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13239 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18152449 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/152449
TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF IN A SUBJECT HAVING INFLUENZA AND A COMPLICATION RISK FACTOR Jan 9, 2023 Abandoned
Array ( [id] => 18931017 [patent_doc_number] => 11883411 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-30 [patent_title] => Use of compound aprepitant in preparation of drug for preventing or treating African swine fever (ASF) [patent_app_type] => utility [patent_app_number] => 17/895390 [patent_app_country] => US [patent_app_date] => 2022-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 3884 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17895390 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/895390
Use of compound aprepitant in preparation of drug for preventing or treating African swine fever (ASF) Aug 24, 2022 Issued
Array ( [id] => 18077294 [patent_doc_number] => 20220402906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => CRYSTAL FORM OF LANIFIBRANOR, PREPARATION METHOD THEREFOR, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/887681 [patent_app_country] => US [patent_app_date] => 2022-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10512 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17887681 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/887681
Crystal form of lanifibranor, preparation method therefor, and use thereof Aug 14, 2022 Issued
Array ( [id] => 19119998 [patent_doc_number] => 11963959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-23 [patent_title] => Inhibitors for coronavirus [patent_app_type] => utility [patent_app_number] => 17/819524 [patent_app_country] => US [patent_app_date] => 2022-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 3242 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819524 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/819524
Inhibitors for coronavirus Aug 11, 2022 Issued
Array ( [id] => 18619115 [patent_doc_number] => 11752137 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-12 [patent_title] => Ophthalmic compositions for treating ocular [patent_app_type] => utility [patent_app_number] => 17/873698 [patent_app_country] => US [patent_app_date] => 2022-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 13483 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17873698 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/873698
Ophthalmic compositions for treating ocular Jul 25, 2022 Issued
Array ( [id] => 18477102 [patent_doc_number] => 11690826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-04 [patent_title] => Methods for treating demodex blepharitis using lotilaner formulations [patent_app_type] => utility [patent_app_number] => 17/873540 [patent_app_country] => US [patent_app_date] => 2022-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 13481 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17873540 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/873540
Methods for treating demodex blepharitis using lotilaner formulations Jul 25, 2022 Issued
Array ( [id] => 18003452 [patent_doc_number] => 20220362218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => METHODS FOR TREATING OCULAR DEMODEX USING SPINOSAD FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/873548 [patent_app_country] => US [patent_app_date] => 2022-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13479 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17873548 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/873548
Methods for treating ocular Jul 25, 2022 Issued
Array ( [id] => 18383368 [patent_doc_number] => 11654132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-23 [patent_title] => Methods for treating COVID-19 [patent_app_type] => utility [patent_app_number] => 17/853355 [patent_app_country] => US [patent_app_date] => 2022-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 41307 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 257 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17853355 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/853355
Methods for treating COVID-19 Jun 28, 2022 Issued
Array ( [id] => 18690914 [patent_doc_number] => 20230321078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => METHOD FOR INHIBITING INFECTION OF SARS-COV-2 IN A SUBJECT [patent_app_type] => utility [patent_app_number] => 17/806274 [patent_app_country] => US [patent_app_date] => 2022-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3057 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17806274 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/806274
Method for inhibiting infection of SARS-CoV-2 in a subject Jun 9, 2022 Issued
Array ( [id] => 17865291 [patent_doc_number] => 20220288026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => METHODS OF TREATING KIDNEY DISEASES [patent_app_type] => utility [patent_app_number] => 17/826832 [patent_app_country] => US [patent_app_date] => 2022-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70308 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826832 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/826832
METHODS OF TREATING KIDNEY DISEASES May 26, 2022 Abandoned
Array ( [id] => 17895316 [patent_doc_number] => 20220304978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => INHIBITING MESANGIAL CELL ACTIVATION [patent_app_type] => utility [patent_app_number] => 17/826753 [patent_app_country] => US [patent_app_date] => 2022-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70296 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826753 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/826753
INHIBITING MESANGIAL CELL ACTIVATION May 26, 2022 Abandoned
Array ( [id] => 18484846 [patent_doc_number] => 20230212154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => TRIAZINE DERIVATIVES HAVING VIRUS REPLICATION INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME [patent_app_type] => utility [patent_app_number] => 17/733366 [patent_app_country] => US [patent_app_date] => 2022-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13396 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17733366 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/733366
Triazine derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the same Apr 28, 2022 Issued
Array ( [id] => 17718997 [patent_doc_number] => 20220211716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 17/655483 [patent_app_country] => US [patent_app_date] => 2022-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20333 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17655483 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/655483
Antiviral prodrugs and nanoformulations thereof Mar 17, 2022 Issued
Array ( [id] => 18328158 [patent_doc_number] => 11633371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-25 [patent_title] => Deuterated forms of acetaminophen and uses thereof [patent_app_type] => utility [patent_app_number] => 17/667465 [patent_app_country] => US [patent_app_date] => 2022-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7257 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667465 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/667465
Deuterated forms of acetaminophen and uses thereof Feb 7, 2022 Issued
Array ( [id] => 18995868 [patent_doc_number] => 11912695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-27 [patent_title] => Benzodiazepine derivatives as RSV inhibitors [patent_app_type] => utility [patent_app_number] => 17/574718 [patent_app_country] => US [patent_app_date] => 2022-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19776 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17574718 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/574718
Benzodiazepine derivatives as RSV inhibitors Jan 12, 2022 Issued
Array ( [id] => 17702763 [patent_doc_number] => 20220202769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => OZONIDES FOR TREATING OR PREVENTING VIRUS INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/570376 [patent_app_country] => US [patent_app_date] => 2022-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8203 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570376 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/570376
Ozonides for treating or preventing virus infections Jan 5, 2022 Issued
Array ( [id] => 17858500 [patent_doc_number] => 11439638 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-09-13 [patent_title] => Drug and diagnostic combination system to identify and treat single-stranded RNA viruses including coronaviruses [patent_app_type] => utility [patent_app_number] => 17/565675 [patent_app_country] => US [patent_app_date] => 2021-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3972 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17565675 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/565675
Drug and diagnostic combination system to identify and treat single-stranded RNA viruses including coronaviruses Dec 29, 2021 Issued
Array ( [id] => 17472423 [patent_doc_number] => 20220079927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-17 [patent_title] => NICORANDIL DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/539146 [patent_app_country] => US [patent_app_date] => 2021-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32163 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17539146 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/539146
NICORANDIL DERIVATIVES Nov 29, 2021 Abandoned
Array ( [id] => 18931021 [patent_doc_number] => 11883415 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-30 [patent_title] => High concentration formulation [patent_app_type] => utility [patent_app_number] => 17/456218 [patent_app_country] => US [patent_app_date] => 2021-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18645 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17456218 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/456218
High concentration formulation Nov 22, 2021 Issued
Array ( [id] => 17441792 [patent_doc_number] => 20220062297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => USE OF GLUCOCORTICOID RECEPTOR ANTAGONISTS IN COMBINATION WITH GLUCOCORTICOIDS TO TREAT ADRENAL INSUFFICIENCY [patent_app_type] => utility [patent_app_number] => 17/525409 [patent_app_country] => US [patent_app_date] => 2021-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14811 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525409 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/525409
Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency Nov 11, 2021 Issued
Menu
This website is using cookies.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn more
x